P16 overexpression in pituitary adenomas studied by immunohistochemistry and in situ hybridization

Chinese Medical Journal

Volumn 113, Issue 2, 2000, Pages 162-166

  Yi, Jing ^a,c   Yu, Derong ^a   Chen, Yuying ^a   Xiong, Wenhao ^a   Li, Xiaoxiong ^a   Shen, Jiankang ^b   Tang, Xueming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Immunohistchemistry; In situ hybridization; p16; Pituitary adenoma

Indexed keywords

CYCLINE; MESSENGER RNA; PROTEIN P16INK4A;

ADENOMA; ADULT; ARTICLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOMA; ADULT; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER;

EID: 0039330944     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707.
2. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-440.
3. Nobori T, Miura K, Wu DJ, et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-756.
4. INK4A in human cancer. Proc Natl Acad Sci U S A 1994;91:11045-11049.
5. Koh J, Enders GH, Dynlacht BD, et al. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 1995;375:506-510.
6. Merlo A, Herman JG, Mao L, et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1: 686-692.
7. INK4A and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res 1996;56:5557-5562.
8. INK4A gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage. Int J Cancer 1997;74:255-259.
9. Marsh KL, Varley JM. Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer 1998;77:1460-1468.
10. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415-417.
11. Spruck CH, Gonzalez-Zulueta M, Shibata A, et al. P16 gene in uncultured tumours. Nature 1994;370:183-184.
12. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDK2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3633.
13. Straume O, Akslen LA. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 1997;74:535-539.
14. INK4A in ovarian cancer is associated with progression and unfavourable prognosis. Int J Cancer 1997;74:57-63.
15. INK4A gene product in human pituitary tumors. Cancer Res 1996;56: 2493-2496.
16. Woloschak M, Yu A, Post KD. Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol Carcinog 1997;19:221-224.
17. INK4B genes in human pituitary adenomas. Eur J Endocrinol 1997;136:74-80.
18. McShea A, Harris PL, Webster KR, et al. Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am J Pathol 1997;150:1933-1939.
19. INK4A expression in human breast cancer. Am J Pathol 1996;149:15-20.
20. INK4A. Cancer Res 1994;54:5816-5820.
21. Bravo R, Frank R, Blundell PA, et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987;326:515-517.
22. Hall PA, Levison DA. Assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-192.
23. Platz A, Sevigny P, Norberg T, et al. Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases. Br J Cancer 1996;74:936-941 .
24. Shigemasa K, Hu C, West CM, et al. P16 overexpression: a potential early indicator of transformation in ovarian carcinoma. J Soc Gynecol Investig 1997;4:95-102.
25. INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer 1997;74:508-512.
26. Asamoto M, Hori T, Baba-Toriyama H, et al. P16 gene overexpression in mouse bladder carcinomas. Cancer Lett 1998;127:9-13.
27. Burns KL, Ueki K, Jhung SL, et al. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas. J Neuropathol Exp Neurol 1998;57:122-130.
28. Dublin EA, Patel NK, Gillett CE, et al. Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters. Int J Cancer 1998;79:71-75.